Driving Innovation with Focus on Staff-Led MedTech, IP Protection, and Genomics Development

Currently, 180 clinical trials are underway, focusing on everything from new surgical devices and drugs to improving understanding of mental health issues. These studies depend on patient participation, and thousands of volunteers contribute each year.

One such project, the BRAID study, focuses on enhancing breast cancer detection for women with dense breast tissue by comparing mammograms with other imaging methods. Despite COVID-19 reducing recruitment, the study surpassed its target with 1,361 participants.

This type of work brings us closer to delivering evidence-based care for our patients, ensuring access to cutting-edge treatments, and fostering innovation amongst staff.

It also supports the co-development of international MedTech innovations, intellectual property protection, commercialisation, and the advancement of genomics services.

Starting on Monday 30th September, we will feature workshops across both sites and a stand in the atrium where the public and staff can learn more about our innovation initiatives.

Workshops will include demonstrations of digital technologies and presentations by key speakers, such as

• Noel Akers, our Trust's patent attorney, leading sessions on managing, protecting, and exploiting intellectual property.
• Claire Richardson, Director of Innovation & Commercial Development, along with Marion Andrews-Evans from the ICB, will discuss regional collaboration in innovation and research.
• James Bristol, Head of Genomics, will conduct genomics workshops focusing on family history taking and broader genomics topics.